Stay updated with breaking news from Biocon Limited. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Equillium, Inc. , a clinical-stage biotechnology company focused on developing novel therapeutics to treat severe autoimmune and inflammatory disorders, today announced that it will present at the...
Biocon Limited partners with Handok Inc. for exclusive licensing of Synthetic Liraglutide in South Korea, targeting weight management market.
Biocon Limited's Q4 FY24 results show a 56.7% profit decline, CEO discusses performance and future roadmaps with BusinessLine.
$40.9 million cash balance at the end of 2023 expected to provide cash runway into 2H 2025 Completed enrollment of Phase 2 clinical study of EQ101 in alopecia areata: topline data expected in Q2...
Kiran Mazumdar-Shaw is founder of Biocon Limited, a biopharmaceutical company which currently has a market cap of more than Rs 347000000000.